Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Researchers explore the potential of bioactive peptides from abalone fish viscera for their antimicrobial and anticancer properties. The study finds promising activity against various bacterial and fungal strains, as well as cytotoxic effects on prostate cancer cells.

Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 31.10.2023 / 13:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

November 1, 2023

AI and imaging advances revolutionize multiple sclerosis diagnosis

A study in Translational Vision Science & Technology reveals that integrating AI with IR-SLO and OCT imaging improves the automated diagnosis and classification of multiple

July 22, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology – Pharmaceutical Technology

ImmunoPrecise Antibodies’ CEO highlighted a growing trend in rabbit monoclonal antibody platform therapeutics, detailing the benefits of the modality. Credit: Richard Constantinoff via Getty Images.

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.